Using a blocking peptide approach, we were able to prevent the plasma membrane mobilization of NHE6, by reducing its binding to the scaffold RACK1, leading to the reversal of endosome hyperacidification and cancer cell sensitization to Dox. The gene discussed is SLC9A6; the disease is cancer.